Emerging Treatment Options in Patients With Difficult-to-Treat Hypertension - Episode 7
Managing hypertension in complex patients involves navigating comorbidities, treatment inertia, and care fragmentation for optimal outcomes.
Summary for Physicians
Challenges in Treating Resistant Hypertension With Third- and Fourth-Line Therapies
The main challenges in using third- and fourth-line therapies for resistant hypertension include:
Cost and Access: These medications can be expensive, and some patients may have limited access due to insurance coverage or financial constraints.
Patient Adherence: Adherence to these therapies may be lower due to complex regimens, adverse effects, or the need for multiple medications.
Addressing these issues requires careful patient education, considering generic options where possible, and ensuring that treatment is both effective and manageable for the patient.